Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methyl iodide | HCID 6328 | — |
| Reactant | Tetrafluoroboric acid | HCID 28118 | — |
| Reactant | Tris(1,1-dimethylethyl)phosphine | HCID 83681 | — |
| Reactant | N-Boc-pyrrolidine | HCID 643455 | — |
| Reactant | Sparteine | HCID 644020 | — |
| Reactant | HCID 59240201 | HCID 59240201 | — |
| Reactant | CID 53628100 | HCID 178418400 | — |
| Catalyst | palladium(II) acetate | HCID 167845 | — |
| Catalyst | Zincchloride | HCID 3007855 | — |
| Solvent | Diethyl Ether | HCID 3283 | — |
| Solvent | Cyclohexane | HCID 8078 | — |
| Solvent | tert-Butyl methyl ether | HCID 15413 | — |
| Product | HCID 44178156 | HCID 44178156 | — |
Reaction Steps
Into a 25 mL round bottom flask was added 480 μL (2.7 mmol) of tert-butyl pyrrolidine-1-carboxylate, 650 μL (2.8 mmol) of (−)-sparteine, and 8 mL of methyl-tert-butyl ether. The resulting solution was cooled in an acetone/dry ice bath. The cold solution was then treated dropwise with 2.4 ml (3.4 mmol) of a 1.4M solution of sec-butyllithium in cyclohexane. After stirring for 90 minutes at −78° C., a small sample of the reaction solution was treated with methyl iodide and analyzed by GC/MS. The GC/MS analysis showed about 60% conversion to the methylated derivative of the lithiated intermediate. After a total of 130 minutes at −78° C., the reaction was treated with 1.8 mL (1.8 mmol) of a 1M solution of ZnCl2 in diethyl ether. The cooling bath was then removed and the reaction was allowed to warm to ambient temperature. After 1 hour at ambient temperature 438 mg (0.77 mmol) of 4-iodo-1-(3′-(methylsulfonyl)biphenyl-4-yl)-2-(2-(trifluoromethyl)phenyl)-1H-imidazole was added as a solution in 2 mL of methyl-tert-butyl ether. The mixture was then treated with 35 mg (160 μmol) of Pd(OAc)2, and 50 mg (170 μmol) of tBu3P.HBF4. The resulting pale brown suspension was heated to 50° C. After stirring for 16 hours at 50° C., most of the solvent had evaporated. The reaction was treated with 10 mL of methyl-tert-butyl ether and a sample analyzed by LC/MS. LC/MS showed no remaining 4-iodo-1-(3′-(methylsulfonyl)biphenyl-4-yl)-2-(2-(trifluoromethyl)phenyl)-1H-imidazole, a quantity of de-iodinated material and a smaller peak that appeared to be product. The reaction mixture was diluted with EtOAc and with 1N HCl. The layers were separated and the acidic aqueous was extracted with EtOAc (3×). Combined organics were washed with saturated aqueous NaHCO3, brine, dried over Na2SO4, filtered and concentrated in vacuo to afford a brown semi-solid. The crude product was purified on the reverse phase preparative HPLC eluting with acetonitrile/water. (Phenomenex Axia Gemini C18 30×100 mm 5 μm, A=H2O with 0.1% trifluoroacetic acid, B=acetonitrile with 0.1% trifluoroacetic acid, 8 minute gradient from 30% B to 65% B at 35 mL/minute). Product fractions were combined, made basic by the addition of sat. NaHCO3, and concentrated in vacuo to remove the acetonitrile. The resulting basic aqueous was extracted with CH2Cl2 (3×), and the organics were dried over Na2SO4, filtered and concentrated in vacuo. The resulting (2R)-tert-butyl 2-(1-(3′-(methylsulfonyl)biphenyl-4-yl)-2-(2-(trifluoromethyl)phenyl)-1H-imidazol-4-yl)pyrrolidine-1-carboxylate was isolated as a clear film; 75 mg (15%). The NMR of the product was very complicated, possibly due to rotamers of the material. Treatment of the CDCl3 NMR sample with 100 μL of trifluoroacetic acid for 65 hours showed complete conversion to a product by NMR. LC/MS analysis of the reaction solution showed a large peak with the correct mass for the desired deprotected amine product.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07998995B2 |
|---|
| Source dataset | uspto-grants-2011_08 |
|---|
| ORD ID | ord-a82b6fe5383d4ea7bf4eb58448a75eb1 |
|---|
| Source note | uspto-grants-2011_08 |
|---|